SCHEMBL10017893

SCHEMBL10017893

Cc1ccc2c(CO)cc3cc4c(cc3c2c1)OCO4

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.50
▸ BCL2L1 Q07817 1/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ BAK1 Q16611 1/20 0.40
▸ CTSL P07711 1/20 0.38
▸ CTSB P07858 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ TSHR P16473 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MAPK1 P28482 2/20 0.37
▸ MAP2K4 P45985 1/20 0.37
▸ MAPKAPK2 P49137 1/20 0.37
▸ MAPKAPK3 Q16644 1/20 0.37
▸ MAPK6 Q16659 1/20 0.37
▸ MAPKAPK5 Q8IW41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10017900 0.85 ALOX5 (0.40) ALOX5BCL2L1MCL1BAK1CTSL
SCHEMBL10049565 0.82 ALOX5 (0.47) ALOX5CTSLCTSBALDH1A1KDM4E
SCHEMBL10017899 0.78 RAB9A (0.41) KDM4ETSHRHSD17B10GAAMEN1
SCHEMBL10017889 0.77 ALDH1A1 (0.47) ALOX5BCL2L1MCL1BAK1ALDH1A1
SCHEMBL10017894 0.74 ALDH1A1 (0.46) CTSLCTSBALDH1A1KDM4ETSHR
SCHEMBL12367123 0.72 TSHR (0.36) TSHRMAPK1MAP2K4MAPKAPK2MAPKAPK3
SCHEMBL14589192 0.68 CYP2A6 (0.56) ALOX5BCL2L1MCL1BAK1ALDH1A1
SCHEMBL26843454 0.68 BCL2L1 (0.80) ALOX5BCL2L1MCL1BAK1ALDH1A1
SCHEMBL10049569 0.68 CTSL (0.44) BCL2L1MCL1BAK1CTSLCTSB
SCHEMBL30968 0.65 ALDH1A1 (0.55) ALDH1A1KDM4ELMNAHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120029018-A1 9-SUBSTITUTED PHENANTHRENE BASED TYLOPHORINE DERIVATIVES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029018-A1 9-SUBSTITUTED PHENANTHRENE BASED TYLOPHORINE DERIVATIVES ABCB1, TYMP, PAH ALOX5 1903/4885BCL2L1 1503/4885MCL1 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback